S
Santhera Pharmaceuticals Holding AG
SIX:SANN
Santhera Pharmaceuticals Holding AG
SIX:SANN
Price:
9.35 CHF
0.11%
Market Closed
Updated:
May 17, 2024
Santhera Pharmaceuticals Holding AG
Other Operating Expenses
|
Santhera Pharmaceuticals Holding AG
Other Operating Expenses Peer Comparison
Comparables:
ADCT
ACIU
CRSP
BSLN
IDIA
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
S
|
Santhera Pharmaceuticals Holding AG
SIX:SANN
|
Other Operating Expenses
CHf622k
|
CAGR 3-Years
8%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
Other Operating Expenses
-CHf3.2m
|
CAGR 3-Years
19%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Other Operating Expenses
CHf0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Idorsia Ltd
SIX:IDIA
|
Other Operating Expenses
-CHf1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is Santhera Pharmaceuticals Holding AG's Other Operating Expenses?
Other Operating Expenses
622k
CHF
622k
CHF
Based on the financial report for Dec 31, 2023, Santhera Pharmaceuticals Holding AG's Other Operating Expenses amounts to 622k CHF.
What is Santhera Pharmaceuticals Holding AG's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
40%
40%
Over the last year, the Other Operating Expenses growth was 516%. The average annual Other Operating Expenses growth rates for Santhera Pharmaceuticals Holding AG have been 8% over the past three years , 40% over the past five years .
You don't have any saved screeners yet
